Catalyst Wire Dossier Catalyst Wire Dossier

PEP005

ingenol mebutate · Peplin
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PEP005, covering 2015-02-12 to 2016-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Determine the Safety of PEP005 0.025% and 0.05% Topical Gel in Patients With Actinic Keratoses [Phase 2]

See pricing